Yep, I thought that was actually a funny one.
Tell me, will it also
- show MSB the way to getting anything approved
- show Novartis where they have to sign to proceed with the agreement
- lead MSB’s management to a trial in which primary end points are met
- show MSB the pathway for fixing their potency quality control issues
- lead MSB to a lender who charges less than 15%pa for its loans
- show MSB where the next batch of suckers are who will need to pump more money in during the next cap raise.
Cell Therapy News/Articles, page-10922
-
- There are more pages in this discussion • 6,899 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.030(2.67%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $2.440M | 2.213M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 149135 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 11390 | 4 |
View Market Depth
| Last trade - 12.18pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |